Cite
HARVARD Citation
Rowe, M. et al. (2022). An analysis of survival in patients with castrate-resistant prostate cancer receiving enzalutamide with treatment breaks. Journal of clinical urology. pp. 257-263. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rowe, M. et al. (2022). An analysis of survival in patients with castrate-resistant prostate cancer receiving enzalutamide with treatment breaks. Journal of clinical urology. pp. 257-263. [Online].